ArticleJournal of racial and ethnic health disparities2026
Assessment of Differences in Colorectal Cancer Outcomes by Geographic Region for Black Patients in the United States.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of the platelet-to-lymphocyte ratio in colorectal cancer patients undergoing chemotherapy: a systematic review and meta-analysis.BMC gastroenterology · 2025Pooled it
- State-level burden of early onset colorectal cancer in the US: a Global Burden of Disease study, 1980 to 2021.Proceedings (Baylor University. Medical Center) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBlack patients have the worst survival outcomes from colorectal cancer (CRC) in the US. In addition, disparities and differences in mortality outcomes among Black and NHW patients across the four US census regions (Northeast [NE], South, West, Midwest [MW]) remain unexplored. We hypothesized that survival outcomes for Black patients would differ across the US census regions and might correlate with socioeconomic factors.
methodsBlack and Non-Hispanic White (NHW) patients ≥ 45 years of age with a diagnosis of colon or rectal adenocarcinoma between 2010 and 2018 were identified in the National Cancer Database for survival analysis. Survival differences were further validated using the Surveillance, Epidemiology, and End Results (SEER) database to investigate 5-year cause-specific survival (CSS).
resultsFor colon adenocarcinoma, the largest difference in median overall survival (OS) between NHW and Black patients was in the MW (67 months Black vs. 74 months NHW, P < 0.001). For rectal cancer, the largest difference was in the West (60 months Black vs. 84 months NHW, P < 0.001). Black patients receiving care in the MW had the lowest median OS for CRC, while those in the NE had the highest (colon: 67 months MW vs. 100 months NE; rectum: 55 months MW vs. 79 months NE). In multivariable analyses of the Black patient cohort, cancer care in the NE was associated with decreased mortality risk compared to other regions.
conclusionGeographic region of care appears to correlate with survival differences for CRC. Exploring these differences may facilitate improved understanding of systemic and structural drivers of health inequities and aid improved resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.